1 min read

December 2024: 3rd Annual Meeting of The Antibody Society of Japan

Picture of KBI Biopharma KBI Biopharma Nov 14, 2024 11:37:00 AM

Conferences

Join KBI Biopharma at The 3rd Annual Meeting of the Antibody Society of Japan

Booth # 3

When: December 9-11, 2024

Where: Sendai, Japan

KBI Biopharma is headed to Sendai for The 3rd Annual Meeting of the Antibody Society of Japan this December!
Schedule a meeting >>

Meet with the KBI Biopharma Team:

Schedule a meeting >>

TOSHIHIRO OGAWA

Senior Director, Business Development

About KBI Biopharma:

KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.

Learn more about KBI Biopharma >>

About the Event:

The 3rd Annual Japan Antibody Society Scientific Conference will be held in a hybrid format in Sendai from December 9-11, 2024. This event offers researchers and students in antibody science a platform to present their work through invited lectures, oral presentations, and poster sessions, with awards for outstanding posters. The conference aims to facilitate knowledge exchange and showcase advancements within the antibody research community.

Learn more >>

Let's Connect

Interested in setting up a time to talk with our team of experts at this event? Looking to follow up on a recent tech talk, presentation, or booth conversation? Let us know! We'd love to hear from you! Fill out the form below and we will be in touch.